Synonym: 17-(Cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium bromide; MNTX; Methylnaltrexonium; Mrz-2663; N-Methylnaltrexone; Naltrexone MB; Quaternary ammonium naltrexone
CAS Number: 73232-52-7
Empirical Formula (Hill Notation): C21H26NO4 · Br
Molecular Weight: 436.34
MDL Number: MFCD06407831
Linear Formula: C21H26NO4 · Br
Product Type: Chemical
This picture is provided solely for illustration purposes, it may have been created or edited with AI. Optical properties of the actual product may deviate. Relevant product information is printed on labeled products and other accompanying or available information material.
This image depicts SML0277-25MG.
| assay |
≥97% (HPLC) |
| color |
white to beige |
| form |
powder |
| InChI |
1S/C21H25NO4.BrH/c1-22(11-12-2-3-12)9-8-20-17-13-4-5-14(23)18(17)26-19(20)15(24)6-7-21(20,25)16(22)10-13;/h4-5,12,16,19,25H,2-3,6-11H2,1H3;1H/t16-,19+,20+,21-,22?;/m1./s1 |
| InChI key |
IFGIYSGOEZJNBE-KNLJMPJLSA-N |
| Quality Level |
100  |
| shipped in |
wet ice |
| SMILES string |
[Br-].C[N@+]1(CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@]2(O)CCC4=O)c35)CC6CC6 |
| solubility |
H2O: ≥5 mg/mL |
| storage condition |
desiccated |
| storage temp. |
−20°C |
| Application: |
Methylnaltrexone bromide has been used as a drug to measure plasma protein binding (PPB), permeability (Pm) and the membrane coefficient (KIAM) for the prediction of blood brain barrier (BBB) penetration. It is also used as a mu-opioid receptor (MOR) antagonist to abrogate morphine tolerance and opioid-induced hyperalgesia (OIH). |
| Biochem/physiol Actions: |
Methylnaltrexone bromide is a narcotic antagonist. |
| Biochem/physiol Actions: |
Methylnaltrexone bromide is a narcotic antagonist. It is a peripheral mu-opiod receptor antagonist that cannot cross the blood-brain barrier. It reverses many opioid side-effects without interfering with pain relief. |
| Features and Benefits: |
This compound is featured on the Opioid Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here . |
| General description: |
Methylnaltrexone does not cross blood brain barrier and does not affect the opioid effects in the brain, such as analgesia. It is used to treat opioid-induced constipation (OIC). |
| Packaging: |
5, 25 mg in glass bottle |
| Hazard Codes |
T,N |
| Risk Statements |
25-50 |
| Safety Statements |
45-61 |
| RIDADR |
UN 2811 6.1 / PGIII |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥97% (HPLC) |
| Storage Temp. |
−20°C |
| UNSPSC |
12352200 |